I spoke with Melanie Farris earlier about the announcement. Here are the main points:
* The standard criteria for measuring statistical significance is ACR20 - a 20% improvement in signs and symptoms
* The placebo was methotrexate (MTX). This is the "gold standard" of current treatments. It was not a sugar pill.
* Sub optimal dosing. 75mg of XToll delivered subcutaneously (into the skin) was not the equivalent of doses previously delivered intravenously
* Management believe continued investigation of XToll is warranted at higher doses
- Forums
- ASX - By Stock
- Ann: Headline Clinical Trial Results
I spoke with Melanie Farris earlier about the announcement. Here...
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CBZ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online